Akero Therapeutics (AKRO) Tops Q2 EPS by 4c

Akero Therapeutics (NASDAQ: AKRO) reported Q2 EPS of ($0.86), $0.04 better than the analyst estimate of ($0.90).

For earnings history and earnings-related data on Akero Therapeutics (AKRO) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Envoy Medical (COCH) PT Lowered to $2 at H.C. Wainwright
• Ross Stores, Inc. (ROST) PT Raised to $239 at UBS on Q2 Earnings Beat